Oceanpine Capital

Oceanpine Capital

A venture capital firm in Hong Kong that focuses on TMT, consumption upgrade, advanced manufacturing, and healthcare sectors.

Oceanpine Capital is a venture capital firm in Hong Kong that focuses on TMT, consumption upgrade, advanced manufacturing, and healthcare sectors. Founded 2017 in Central, Hong Kong Island by David Liguang Chenn, it invests in early stage ventures and late stage ventures. Its portfolio companies include Apexigen, Ansun BioPharma, Enflame, Horizon Robotics, Rgenix, 51zhaoyou.com, Tiger Brokers, and Ansun BioPharma. As of March 2020, Oceanpine Capital has made eight investments. Their most recent investment was on March 24, 2020, when Apexigen raised $65M. Oceanpine Capital has had one exit, which was Tiger Brokers.

Timeline

2017

Founded

Funded Companies

Company
Description
Website
Industry
Location
2 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

David Liguang Chenn Chenn

Chief executive officer

Adam Sun

Managing Partner

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Enflame

51zhaoyou.com

Ansun BioPharma

Horizon Robotics

Rgenix

Tiger Brokers

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.